Phosphorylation by p38 MAPK as an alternative pathway for GSK3β inactivation

TM Thornton, G Pedraza-Alva, B Deng, CD Wood… - Science, 2008 - science.org
TM Thornton, G Pedraza-Alva, B Deng, CD Wood, A Aronshtam, JL Clements, G Sabio
Science, 2008science.org
Glycogen synthase kinase 3β (GSK3β) is involved in metabolism, neurodegeneration, and
cancer. Inhibition of GSK3β activity is the primary mechanism that regulates this widely
expressed active kinase. Although the protein kinase Akt inhibits GSK3β by phosphorylation
at the N terminus, preventing Akt-mediated phosphorylation does not affect the cell-survival
pathway activated through the GSK3β substrate β-catenin. Here, we show that p38 mitogen-
activated protein kinase (MAPK) also inactivates GSK3β by direct phosphorylation at its C …
Glycogen synthase kinase 3β (GSK3β) is involved in metabolism, neurodegeneration, and cancer. Inhibition of GSK3β activity is the primary mechanism that regulates this widely expressed active kinase. Although the protein kinase Akt inhibits GSK3β by phosphorylation at the N terminus, preventing Akt-mediated phosphorylation does not affect the cell-survival pathway activated through the GSK3β substrate β-catenin. Here, we show that p38 mitogen-activated protein kinase (MAPK) also inactivates GSK3β by direct phosphorylation at its C terminus, and this inactivation can lead to an accumulation of β-catenin. p38 MAPK–mediated phosphorylation of GSK3β occurs primarily in the brain and thymocytes. Activation of β-catenin–mediated signaling through GSK3β inhibition provides a potential mechanism for p38 MAPK–mediated survival in specific tissues.
AAAS